🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chronic-phase chronic myelogenous leukemia (CML) a...
Status
Unknown
Location
the First Affiliated Hospital of Harbin Medical University
Start Date
2018-05-01
Trial ID
NCT03515018
Treatments Being Tested
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
Open-labeled, multicenter, phase I/II study of imatinib combined with ESHAP...
Status
Unknown
Location
Dong-A University Hospital
Start Date
2015-02
Trial ID
NCT02431403
Treatments Being Tested
The purpose of this study is to determine a maximum tolerated dose and/or r...
Status
Completed
Location
Dana Farber Cancer Institute SC (2)
Start Date
2012-04-20
Trial ID
NCT01468688
An open label randomised trial for adults with histologically confirmed mea...
Status
Unknown
Location
Canberra Hospital
Start Date
2015-06-30
Trial ID
NCT02365441
Treatments Being Tested
This is a single center, four-treatment, four period, crossover study to ev...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00422825
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Duke Cancer Institute
Start Date
2005-05
Trial ID
NCT00354913
Treatments Being Tested
The purpose of this study is to compare the relapse free survival and overa...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2012-08
Trial ID
NCT01782508
Treatments Being Tested
The purpose of this study is to evaluate safety and tolerance by comparing ...
Status
Completed
Location
The Korea University Anam Hospital
Start Date
2010-11
Trial ID
NCT01270984
Treatments Being Tested
The extension study followed the core study CAMN107ECN02 (NCT01275196). whi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-07-17
Trial ID
NCT02272777